There are the five pillars of our Common Ground framework, a methodology for multi-stakeholder engagement that puts patient communities at the center, not the margins. Read the whitepaper: lumanity.com/perspectives...

What does it take to transform rare disease? Collaboration. Courage. And community. Our Voices of Rare Disease series is now complete. Watch all four stories: lumanity.com/perspectives... #VoicesOfRareDisease #Lumanity #RareDiseaseAdvocacy

5 questions. Run them before you write a brief. Run them again before final approval. Download the Behavioral Barrier Checklist: lumanity.com/perspectives...

We are proud supporters of Light the Night by Blood Cancer United, raising money to fund treatments for patients who are dealing with all forms of blood cancers. Get involved or support Light the Night: buff.ly/sg0dq1K #LightTheNight #BloodCancerUnited #BloodCancer

Join Michael Parisi, John Howley, and Jess Berard at the BIONJ C-Suite Summit on October 15. Want to connect while in Bridgewater? Reach out to our staff directly or email contact@lumanity.com to find time on-site. For more on the event, visit bionj.org/event/2026-b...

MFN drug pricing is all over the headlines, but the mechanics have more limits than they suggest. 📄 Our Market Access Strategy team’s new whitepaper covers 3 structural factors that limit MFN’s reach, from exemptions to launch timing to ex-US decisions. Download: lumanity.com/perspectives...

Heading to #ISPOREurope2026 in Vienna? Our experts will be at booth #611, ready to help you navigate evolving policy shifts, shape compelling value stories, and share insights. Find out more on our website: lumanity.com/events/ispor...

In this live webinar, panelists unpack what it really takes to build partnerships that last, and how to tell the difference between genuine engagement and performative check-the-box efforts. Register for the live conversation: buff.ly/kevRRbt

Convinced HCPs still aren't acting? The barrier isn't the data. It's usually confidence, friction, or habit. See the framework: lumanity.com/perspectives...

Four advocates. Four conditions. Four communities transformed by the courage to speak up, push back, and drive change. Watch the full Voices of Rare Disease series: lumanity.com/perspectives... #RareDisease #HealthcareAdvocacy #PatientCommunity

Ed Saltzman will join venture capitalists, investors, and private equity experts on an insightful GCRIS panel; “Navigating the Nexus of Capital Markets, Cancer Innovation and Policy.” Learn more: buff.ly/yRR8ayI October 5, 2026 | 2:00pm – 2:50pm | New York, NY

Jakub Kaczor, PhD and Peter Smith unpack the complexities of portfolio positioning and how to mitigate the risks of assets competing against each other in the same disease area. Watch now: buff.ly/wKE7Zj6

Quick test: can two people on your team describe your target HCP behavior the same way? If not, you have a vague goal, not a defined behavior. Download the checklist to optimize your next brief: lumanity.com/perspectives...

Jeff Bockman will join investors, VCs and private equity experts at the Global Cancer Research & Innovation Symposium panel; “Global Trends and Reality Checks on the State of Cancer Research.” Learn more: buff.ly/yRR8ayI October 6, 2026 | 8:00am – 9:00am | New York, NY

Michael Rice will be in Phoenix for the Meeting on the Mesa! As a leader in the cell, gene and advanced therapy community, he's ready to discuss the latest advances, challenges and opportunities shaping this rapidly evolving field. Don't miss the opportunity to connect!

Join us for Common Ground: When Patients, Providers and Pharma Build Partnerships That Last. Some of the most meaningful progress in healthcare happens when patients, advocates, providers, and pharma work toward the same goal. But holding that common ground is harder than it sounds. buff.ly/bOysufE

Skip the guesswork. Get our Expert Navigator quick reference guide, watch the walkthrough, or request a custom demo—see the right experts, faster. lumanity.com/products/exp... #ExpertNavigator #MedicalAffairs #KOLEngagement #LifeSciences

Everyone wants to know what's behind the curtain on the Most-Favored-Nation deals. Moira Ringo, VP, Market Access Strategy at Lumanity, shares what to look for beyond the headline in FirstWord PHARMA's “Spotlight On”: price is only one piece. lumanity.com/perspectives...

Every voice in rare disease carries a story—and every story has the power to change things. Watch the full Voices of Rare Disease series: lumanity.com/perspectives... #RareDisease #PatientVoice #VoicesOfRareDisease

Steve Mather shares valuable insights on how IRA revenue horizons, Europe’s JCA, and MFN cross-border pricing dynamics don’t just add complexity - together, they multiply constraints on value and force critical choices earlier than most development playbooks assume. Watch: buff.ly/8gUv1Pp

Will you be at this week's #ISMPPAcademy? Get a first look at the toolkit and gain access to a practical framework to connect evidence, stakeholder needs, and scientific goals. whova.com/web/vowri1FB... #PublicationPlanning #ISMPPAcademy #MedComms #SciComms

We're counting down to the 2026 European Academy of Dermatology & Venereology (EADV) meeting focused on skin and sexual health. Will you be there? Email contact@lumanity.com to find time to connect. For more information on the meeting, visit eadv.org/congress/ #EADV2026 #Dermatology #Venereology

Jillian Cunningham is heading to the annual Cell & Gene Meeting on the Mesa! Don't miss this opportunity to meet with a market access expert who wants to hear about your challenges and opportunities in the cell, gene, and advanced therapy space and share how Lumanity can help.

We are honored to share the story of Krystyn LaBate, PhD in our Voices of Rare Disease series. Krystyn founded the CMCD Foundation to change the lack of resources and awareness her family faced when affected by rare disease. Hear her perspective here. lumanity.com/perspectives...

Ranking KOLs by publication count alone misses the digital opinion leaders & patient advocates who actually move the needle. Multi-signal analytics + 20 yrs of methodology = the right experts, faster. lumanity.com/products/exp... #ExpertNavigator

Michael Rice will be in Phoenix for the Meeting on the Mesa! As a leader in the cell, gene and advanced therapy community, he's ready to discuss the latest advances, challenges and opportunities shaping this rapidly evolving field. Don't miss the opportunity to connect! Email contact@lumanity.com

Will you be at next week's Intellus Worldwide Institute & Awards Celebration? If so, reach out to contact@lumanity.com to find time to meet on-site. For more information about the conference, visit www.intellus.org/Events-Webin... #MarketResearch #MarketInsights #HealthInsights #IntellusInstitute

"They say they believe the data, but they're not prescribing it." That's not an awareness problem. More reach won't fix it. Read why: lumanity.com/perspectives...

Launch experts Andrew Mooney and Laurence Cooper unpack the complexity and pressure of pharma launches for first-time and small organizations. Listen Now: buff.ly/G1ZNENc

Kirsty Tait and Jeff Hart explore how pharmaceutical companies can scale launch excellence as their pipelines grow and complexity increases. Listen now: buff.ly/xfqE3kO